| Company/Division name | Sun Pharmaceutical Industries |
| Parent company | Sun Pharmaceutical Industries |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 220 |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2026 |
| Country(ies) from which reshored: | India |
| City reshored to: | Princeton |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Impact on domestic economy, Infrastructure, Skilled workforce availability/training |
| Government Incentive dollar amount: | 5,236,000 |
